As CIP/KIP CDK inhibitors promote dephosphorylated state of pocket proteins (retinoblastoma (Rb), p107 and p130) thereby exercising control over G1/S transition, we evaluated whether they might play a role in G1/S checkpoint activation in CLL cells treated with MLN4924. The gene discussed is RB1; the disease is B-cell chronic lymphocytic leukemia.